X

Interviews

Unicycive is all-in on kidney care, focusing on underserved areas: CEO

Unicycive Therapeutics, Inc. (NASDAQ: UNCY) is a biotech firm engaged in the development of novel treatment options for patients with…

Advantage of CERo’s CER receptor lies in native human protein-based antigen binding: CEO

CERo Therapeutics Holdings, Inc. is a biotechnology company pioneering engineered T cell immunotherapies to combat cancer, with a focus on…

Kairos Pharma’s goal is to intervene early in resistance and re-sensitize cancer cells to therapy: CEO

Kairos Pharma, Ltd. (NYSE: KAPA) is a biopharma company developing a pipeline of targeted therapies for cancer patients with high…

Our differentiation is validated by strong, sustainable unit economics: Prenetics CEO

Prenetics Global Limited (NASDAQ: PRE), headquartered in Hong Kong, is a health sciences company active in genomics, diagnostics, and consumer…

Inspire Veterinary Partners has a focus on long-term relationship with stakeholders: CEO

Inspire Veterinary Partners (NASDAQ: IVP) operates a growing network of veterinary hospitals across the US, specializing in small animal care…

Strategic partnerships have been essential to Profusa’s progress: CEO Ben Hwang

Profusa, Inc. (NASDAQ: PFSA) is a digital health company pioneering a new generation of biointegrated sensors. Its injectable biosensors are…

Plus Therapeutics CEO: Lead candidate REYOBIQ demonstrates strong safety and efficacy in early trials

Plus Therapeutics (NASDAQ: PSTV) is a pharmaceutical company engaged in the development of targeted radiotherapeutics for difficult-to-treat cancers. Currently, it…

OS Therapies is actively advancing its osteosarcoma immunotherapy: CEO Paul Romness

OS Therapies (NYSE: OSTX) is a cancer immunotherapy company engaged in the development of new treatments for osteosarcoma and other…

Rezolve Ai enhances shopping experience for customers and retailers: Deputy CEO

Rezolve Ai (NASDAQ: RZLV) is on a mission to revolutionize the retail industry by offering customers a new shopping experience…

“Gelteq has been continuously evolving to expand applications and audiences”

Gelteq Limited (NASDAQ: GELS) is a healthcare company specializing in the development and manufacturing of edible gel products, with a…